NCT07411690 Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors
| NCT ID | NCT07411690 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Warsaw |
| Condition | Brain Tumor Adult |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-02-03 |
| Primary Completion | 2028-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2026-02-03 with a primary completion date of 2028-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cerebrospinal fluid is a clear fluid that surrounds and protects the brain. During surgery for brain tumors, neurosurgeons often need to open the covering of the brain (the dura) to reach the tumor. At the end of the operation, this covering is carefully closed again. In some cases, the closure might not be completely adequate leading to cerebrospinal fluid leak. This leakage may collect under the scalp or flow out through the surgical wound. When this happens, the surgical wound may not heal properly, and the risk of infection can increase. These complications can delay recovery and may postpone additional treatments, such as radiotherapy or chemotherapy, that are often needed after brain tumor surgery. Although cerebrospinal fluid leakage is less common after supratentorial craniotomy (surgery on the upper part of the brain) than after other types of brain surgery, it remains a challenging complication and has not been well studied in this group of patients. The aim of this study is to determine how often cerebrospinal fluid leakage occurs after supratentorial craniotomy for intracranial tumors, identify factors that increase the risk of leakage, and evaluate how these leaks are managed. Understanding these factors may help reduce the occurrence of cerebrospinal fluid leakage and improve postoperative recovery in the future.
Eligibility Criteria
Inclusion Criteria: * Male or female at least 18 years old * Qualified for a craniotomy due to supratentorial intracranial tumor Exclusion Criteria: * Revision surgery due to recurrent brain tumor * Emergency neurosurgical procedure
Contact & Investigator
Michal Senger, M.D.
PRINCIPAL INVESTIGATOR
Department of Neurosurgery, Medical University of Warsaw, Warsaw, Poland
Frequently Asked Questions
Who can join the NCT07411690 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Brain Tumor Adult. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07411690 currently recruiting?
Yes, NCT07411690 is actively recruiting participants. Contact the research team at michal.senger@wum.edu.pl for enrollment information.
Where is the NCT07411690 trial being conducted?
This trial is being conducted at Warsaw, Poland.
Who is sponsoring the NCT07411690 clinical trial?
NCT07411690 is sponsored by Medical University of Warsaw. The principal investigator is Michal Senger, M.D. at Department of Neurosurgery, Medical University of Warsaw, Warsaw, Poland. The trial plans to enroll 200 participants.